Fibroids

Lori Solomon MONDAY, May 15, 2023 (HealthDay News) -- Fibroids are associated with an increased risk for ovarian cancer in both Black and White women, with risk modified by hysterectomy status,…

MONTREAL, July 21, 2022 (GLOBE NEWSWIRE) -- Today, Vivre 100 Fibromes (Living Without Fibroids) officially declared July 21st as the first Fibroids Awareness Day in Canada – a date to increase understanding and shine a light on uterine…

  -Yselty® (linzagolix) is the first and only approved GnRH antagonist to provide flexible dosing options with and without hormonal add-back therapy- -Theramex to commercialize Yselty®; ObsEva to receive royalties on commercial sales,…

-Yselty® (linzagolix) is the first and only approved GnRH antagonist to provide flexible dosing options with and without hormonal add-back therapy-   -Theramex to commercialize Yselty®; ObsEva to receive royalties on commercial sales,…

-Additional data from the PRIMROSE Phase 3 studies of linzagolix featured in four posters. Oral presentation took place on May 8, 2022 at 9:15am PT/12:15pm ET- GENEVA, Switzerland May 9, 2022 – ObsEva SA (NASDAQ: OBSV; SIX: OBSN), a…

Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange GENEVA, Switzerland – April 25, 2022 – ObsEva SA (NASDAQ: OBSV; SIX: OBSN), a biopharmaceutical company developing and commercializing novel therapies for women’s…

By Express News Service A woman should feel empowered to do what she wishes to accomplish in her life, related to career, education, her family and other things. To achieve all of these, the basic foundation is…

Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange   GENEVA, Switzerland – February 4, 2022 – ObsEva SA (NASDAQ: OBSV; SIX: OBSN), a biopharmaceutical company developing and commercializing novel therapies for women’s…

Rapper, former "The Talk" co-host, and actress Eve, 43, announced that she is taking maternity leave from her ABC show "Queens." She and her…

A 43-year-old Australian woman presented to the emergency department with concerns related to dyspnea, urinary frequency, and heavy menstrual…